TechSeeker Profile

Daiichi Sankyo Co Ltd
Profile last edited on: 3/22/2022

NO Business Identifier is currently available for this company.
TS Type
Major Corporation
Status
Active
Year Founded
2005
Last Involved Year
2018

Key People / Management

Location Information

Two Hilton Court
Parsippany, NJ 07054
   (973) 359-2600
   www.dsi.com

Public Profile

Daiichi Sankyo Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd., which is a global pharmaceutical innovator. The headquarters company was established in 2005 from the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo’s research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes and acute coronary syndrome. Also important to the company is the discovery of new medicines in the areas of infectious diseases, cancer, bone and joint diseases, and immune disorders. DAIICHI SANKYO COMPANY, LIMITED is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
15,348
Revenue
N/A
Public/Private
Publicly Traded
Stock Info
TYO- Tokyo : 4568
Received SBIR $$
No